Skip to main content
Have a personal or library account? Click to login
Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study Cover

Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study

Open Access
|Apr 2020

References

  1. WHO. Global brief on hypertension. World Health Organization; 2013.
  2. Esteghamati A, Etemad K, Koohpayehzadeh J, et al. Awareness, Treatment and Control of Pre-hypertension and Hypertension among Adults in Iran. Arch Iran Med. 2016; 19(7): 45664.
  3. Bozorgmanesh M, Hadaegh F, Mehrabi Y, et al. A point-score system superior to blood pressure measures alone for predicting incident hypertension: Tehran Lipid and Glucose Study. J Hypertens. 2011; 29(8): 14861493. DOI: 10.1097/HJH.0b013e328348fdb2
  4. Sun D, Liu J, Xiao L, et al. Recent development of risk-prediction models for incident hypertension: An updated systematic review. PloS One. 2017; 12(10): e0187240. DOI: 10.1371/journal.pone.0187240
  5. Asgari S, Khalili D, Mehrabi Y, et al. Incidence and risk factors of isolated systolic and diastolic hypertension: a 10 year follow-up of the Tehran Lipids and Glucose Study. Blood Press. 2016; 25(3): 177183. DOI: 10.3109/08037051.2015.1116221
  6. Coogan PF, White LF, Jerrett M, et al. Air pollution and incidence of hypertension and diabetes mellitus in black women living in Los Angeles. Circulation. 2012; 125(6): 767772. DOI: 10.1161/CIRCULATIONAHA.111.052753
  7. Salem H, Hasan DM, Eameash A, et al. Worldwide Prevalence Of Hypertension: A Pooled Meta-Analysis Of 1670 Studies In 71 Countries With 29.5 Million Participants. J Am Coll Cardiol. 2018; 71(11 Supplement): A1819. DOI: 10.1016/S0735-1097(18)32360-X
  8. Talaei M, Sadeghi M, Mohammadifard N, et al. Incident hypertension and its predictors: the Isfahan Cohort Study. J Hypertens. 2014; 32(1): 3038. DOI: 10.1097/HJH.0b013e32836591d4
  9. Arici, M, Turgan C, Altun B, et al. Hypertension incidence in Turkey (HinT): a population-based study. J Hypertens. 2010; 28(2): 2404. DOI: 10.1097/HJH.0b013e328332c36b
  10. Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009; 10(1): 5. DOI: 10.1186/1745-6215-10-5
  11. Hadaegh F, Zabetian A, Sarbakhsh P, et al. Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population. Int J Obes (Lond). 2009; 33(12): 1437. DOI: 10.1038/ijo.2009.180
  12. Committee, IR. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms; 2005. http://www. ipaq.ki.se/scoring.pdf. (Access date: 04/01/2020).
  13. Matsushita K, Selvin E, Bash LD, et al. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2010; 55(4): 648659. DOI: 10.1053/j.ajkd.2009.12.016
  14. Alberti K, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009; 120(16): 16401645. DOI: 10.1161/CIRCULATIONAHA.109.192644
  15. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 30213104. DOI: 10.1093/eurheartj/ehy339
  16. Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardization of rates: a new WHO standard. Geneva: World Health Organization. 2001; 9(10).
  17. Mazumdar M, Glassman JR. Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. Stat Med. 2000; 19(1): 113132. DOI: 10.1002/(SICI)1097-0258(20000115)19:1<;113::AID-SIM245>3.0.CO;2-O
  18. Harrell, FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15(4): 36187. DOI: 10.1002/(SICI)1097-0258(19960229)15:4<;361::AID-SIM168>3.0.CO;2-4
  19. Cenzer IS, Miao Y, Kirby K, Boscardin WJ. Estimating Harrell’s optimism on predictive indices using bootstrap samples. InSAS Global Forum. 2013; (Vol. 2013).
  20. Perneger TV. What’s wrong with Bonferroni adjustments. Bmj. 1998; 316(7139): 12361238. DOI: 10.1136/bmj.316.7139.1236
  21. Mansournia MA, Altman DG. Inverse probability weighting. Bmj. 2016; 352: i189. DOI: 10.1136/bmj.i189
  22. Kshirsagar AV, Chiu, Yl, Bomback AS, et al. A hypertension risk score for middle-aged and older adults. J Clin Hypertens (Greenwich). 2010; 12(10): 800808. DOI: 10.1111/j.1751-7176.2010.00343.x
  23. Kivimaki M, Tabak AG, Batty GD, et al. Incremental predictive value of adding past blood pressure measurements to the Framingham hypertension risk equation: The Whitehall II Study. Hypertension. 2010; 55(4): 105862. DOI: 10.1161/HYPERTENSIONAHA.109.144220
  24. Lee S-H, Kim Y-S, Sunwoo S, Huh B-Y. A retrospective cohort study on obesity and hypertension risk among Korean adults. J Korean Med Sci. 2005; 20(2): 188195. DOI: 10.3346/jkms.2005.20.2.188
  25. Fidalgo ASQ, Vollenweider P, Marques-Vidal P. Ten-year incidence of hypertension in a Swiss population-based sample Incidence of hypertension in Switzerland. J Hum Hypertens. 2019; 33(2): 115. DOI: 10.1038/s41371-018-0116-4
  26. DuPont JJ, Kenney RM, Patel AR, Jaffe IZ. Sex differences in mechanisms of arterial stiffness. Br J Pharmacol; 2019. DOI: 10.1111/bph.14624
  27. Dannenberg AL, Garrison RJ, Kannel WB. Incidence of hypertension in the Framingham Study. Am J Public Health. 1988; 78(6): 676679. DOI: 10.2105/AJPH.78.6.676
  28. Diederichs C, Neuhauser H. The incidence of hypertension and its risk factors in the German adult population: results from the German National Health Interview and Examination Survey 1998 and the German Health Interview and Examination Survey for Adults 2008–2011. J Hypertens. 2017; 35(2): 250258. DOI: 10.1097/HJH.0000000000001151
  29. Robitaille C, Dai S, Waters C, et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ. 2012; 184(1): E49E56. DOI: 10.1503/cmaj.101863
  30. Colafella KMM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018; 14(3): 185. DOI: 10.1038/nrneph.2017.189
  31. Chen Y, Wang C, Liu Y, et al. Incident hypertension and its prediction model in a prospective northern urban Han Chinese cohort study. J Hum Hypertens. 2016; 30(12): 794. DOI: 10.1038/jhh.2016.23
  32. Parikh NI, Pencina MJ, Wang TJ, et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med. 2008; 148(2): 102110. DOI: 10.7326/0003-4819-148-2-200801150-00005
  33. Jayedi A, Rashidy Pour A, Khorshidi M, et al. Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and dose–response meta-analysis of more than 2.3 million participants. Obes Rev. 2018; 19(5): 654667. DOI: 10.1111/obr.12656
  34. Arshi B, Tohidi M, Derakhshan A, et al. Sex-specific relations between fasting insulin, insulin resistance and incident hypertension: 8.9 years follow-up in a Middle-Eastern population. J Hum Hypertens. 2015; 29(4): 260. DOI: 10.1038/jhh.2014.70
  35. Derakhshan A, Tohidi M, Hajebrahimi M, et al. Sex-specific incidence rates and risk factors of insulin resistance and β–cell dysfunction: a decade follow-up in a Middle Eastern population. Diabet Med. 2017; 34(2): 245252. DOI: 10.1111/dme.13117
  36. Bozorgmanesh M, Ghoreishian H, Mohebi R, et al. Sex-specific predictors of the prehypertension-to-hypertension progression: community-based cohort of a West-Asian population. Eur J Prev Cardiol. 2014; 21(8): 956963. DOI: 10.1177/2047487313481757
  37. Ramezankhani A, Azizi F, Hadaegh F. Associations of marital status with diabetes, hypertension, cardiovascular disease and all-cause mortality: A long term follow-up study. PLoS One. 2019; 14(4): e0215593. DOI: 10.1371/journal.pone.0215593
  38. Ebina T. Smoking and Incident Hypertension- Importance of Cotinine-Verified Smoking Status. Circ J. 2018; 82(6): 15101512. DOI: 10.1253/circj.CJ-18-0399
  39. Janzon E, Hedblad B, Berglund G, Engström G. Changes in blood pressure and body weight following smoking cessation in women. J Intern Med. 2004; 255(2): 266272. DOI: 10.1046/j.1365-2796.2003.01293.x
  40. Vischer AS, Burkard T. Principles of Blood Pressure Measurement – Current Techniques, Office vs Ambulatory Blood Pressure Measurement. Adv Exp Med Biol. 2017; 956: 8596. DOI: 10.1007/5584_2016_49
  41. Wu L, Sun D, He Y. Fruit and vegetables consumption and incident hypertension: dose–response meta-analysis of prospective cohort studies. J Hum Hypertens. 2016; 30(10): 573. DOI: 10.1038/jhh.2016.44
DOI: https://doi.org/10.5334/gh.780 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jul 28, 2019
Accepted on: Feb 26, 2020
Published on: Apr 8, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Samaneh Asgari, Seyyed Saeed Moazzeni, Fereidoun Azizi, Hengameh Abdi, Davood Khalili, Monir Sadat Hakemi, Farzad Hadaegh, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.